Travel Health and Vaccines Slideshow Pictures

Medical Author:

Mai Kim Lai, MD

Coauthor:

Douglas C Finefrock, DO

Coauthor:

Gregory L Walker, MD, FACEP, Ped EM

Medical Editor:

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

View Full Profile

(Hib)

Selected conditions exist in which Haemophilus influenzae type b (Hib) conjugate vaccine may be used for adults. Hib vaccines are licensed for children 6 weeks to 71 months of age. No efficacy data is available on which to base a recommendation concerning the use of Hib vaccine for older children and adults with the chronic conditions associated with an increased risk for Hib disease. However, studies suggest that Hib vaccine may be beneficial in patients who have sickle cell disease, leukemia, or HIV infection, or have had splenectomies.